The second day and final day of Ceva Animal Health’s seminar entitled ‘The guards of a century: 100 years with Newcastle disease’ in Bogor, Indonesia, centered on vaccine breakthroughs.
Atsushi Yasuda and Moto Esaki of Ceva Japan traced the history of vector vaccine development, explained design considerations for HVT vector vaccines, and outlined future directions.
They described the trial-and-error process behind the early HVT-F vaccine and recalled how development of the HVT/ND vaccine began in 1985. Candidate selection in those early years laid the foundation for today’s advances.
“Future HVT vector vaccine development will incorporate advanced antigen design supported by artificial intelligence and bioinformatics,” said Mr Esaki.
Discovering the strength of eHVT-F technology
Dr Vilmos Palya, Ceva’s Scientific Support Expert, highlighted the immune response advantages of rHVT-F technology.
“Traditional ND vaccines prevent the clinical disease, but do not prevent infection and subsequent virus shedding. Vectormune ND delivered in-ovo or day-old s. c. proved to provide great potential for early and lifelong induction of active immunity in face of MDA, without inducing respiratory reaction,” he explained.
Professor Arjan Stegeman of Utrecht University then addressed how vaccine effectiveness against NDV transmission can be measured. Using data from commercial broilers exposed to velogenic genotype VII NDV, he demonstrated that vector rHVT-F vaccines significantly reduce transmission rates.
Proven protection against emerging genotypes
Ceva Consultant Dr. Marcelo Paniago presented extensive challenge trial results confirming rHVT-F vaccine efficacy against emerging velogenic NDV genotypes.
Findings showed that Vectormune ND consistently provided maximum protection across all NDV genotypes. It offered early onset and lifelong immunity while reducing virus shedding and transmission.
Closing the seminar, Mustafa Seckin Sandikli, Ceva’s Global Poultry Director, reaffirmed Ceva’s commitment to advancing animal health solutions worldwide.
“As there is only one serotype [of NDV], the genotype of the vaccine is not relevant. Thus, the critical point is the concept and technology of the vaccine choice. Vectormune ND has proven results against each genotype in different challenge conditions,” he stressed.
Subscribe now to the poultry technical magazine
AUTHORS
Newcastle Disease: One Hundred Years On, Why Transmission Control Matters More Than Ever
Mustafa Seckin Sandikli
Egg Size Versatility in Nick Chick – Part I
H&N Technical Department
Interview with Khaled Abdel Nasser Awwad
Khaled Abdel Nasser Awwad
When the Supply Chain Breaks: Poultry Prices and the Economics of Maritime Disruption in the Middle East
Dima Chatila
Reovirus Infections in the Broiler Industry
Edgar O. Oviedo Rondón
Egg Condensation in Hatcheries: A Hidden Risk for Embryo Development, Hatchability and Chick Quality
Rasel Ahmed
From Chat to Farm Insight: Bridging the Social Data Gap in Indonesian Broiler Farming
Setiawan Guntarto
Labor Shortage in the Poultry Industry: Potential Solutions
Edgar O. Oviedo Rondón
A Comparison of Soybean Meal from Different Origins in Terms of Nutrient Composition, Amino Acid Profile, and Protein Quality
Güner GÖVENÇ
When Algorithms Start to Control Feed Composition
Henri E. Prasetyo DVM. M.Vsc
